ライフサイエンスコーパス: clinical decision rule

1 gh risk for GAS pharyngitis as assessed by a clinical decision rule.

2 -L1) contributed the most improvement to the clinical decision rules.

3 PE can be safely excluded based on a clinical decision rule and D-dimer testing in patients w

4 isms may also be safely characterized by the clinical decision rule and spared radiation exposure.

5 , involving both non-invasive bedside tools (clinical decision rules and D-dimer blood tests) for pat

6 Novel clinical decision rules and laboratory assays to improve

7 needed in development of pediatric-specific clinical decision rules and risk stratification and in t

8 Clinical decision rules are able to predict intra-abdomi

9 Clinical decision rules attempt to formally test, simpli

10 prospectively completed data forms for each clinical decision rule before the patients' CT scans.

11 Clinical decision rules can help to determine the need f

12 history and physical examination features in clinical decision rules can identify patients with minor

13 A clinical decision rule (CDR) is a clinical tool that qua

14 ) positive throat culture (culture all); (3) clinical decision rule (CDR) score >/=2 (CDR 2+); (4) CD

15 We aim to develop an ultrasound-based clinical decision rule (CDR) to confidently rule-out the

16 of this study was to develop and validate a clinical decision rule (CDR) to predict 1-month serious

17 dictive accuracy of such risk stratification clinical decision rules (CDR) for children and young peo

18 the safety of excluding PE on the basis of a clinical decision rule combined with D-dimer testing.

19 e of analytic studies spanning epidemiology, clinical decision-rule development, and electronic tool

20 INTERPRETATION: The sensitivities of three clinical decision rules for head injuries in children we

21 Use of the clinical decision rule had a favorable impact on physici

22 Recently, validated clinical decision rules have been developed that avoid u

23 Clinical prediction rules, sometimes called clinical decision rules, have proliferated in recent yea

24 The clinical decision rules included the Canadian CT Head Ru

25 ignificantly improved the performance of the clinical decision rules, independently of UCH-L1.

26 h has focused on implementation of validated clinical decision rules into practice to reduce unnecess

27 e and abuse, but differences identified by a clinical decision rule may allow improved and earlier re

28 re (eg, imaging in children at low risk on a clinical decision rule), patient-centered care (eg, desi

29 We aimed to validate three clinical decision rules (PECARN, CATCH, and CHALICE) in

30 How this blood test compares with validated clinical decision rules remains unknown.

31 substantially; however, the Grote and Saari clinical decision rules seem the most promising.

32 uted tomography in patients at low-risk on a clinical decision rule, stabilization of femoral shaft f

33 tively derived and internationally validated clinical decision rule that enables point-of-care risk a

34 Several clinical decision rules that may be helpful in identifyi

35 This algorithm should always include a clinical decision rule to assess the likelihood that PE

36 onditions and with internationally validated clinical decision rules to define abnormal growth, inclu

37 Despite the recent validation of clinical decision rules to limit the use of CTPA, an inc

38 An adaptation of a previously validated clinical decision rule was adopted as the standard of ca

39 Three clinical decision rules were previously derived to ident

40 The use of clinical decision rules will require local validation be

41 A strategy of using a clinical decision rule without culturing is overall the